All terms in BAO
| Label | Id | Description |
|---|---|---|
| ovarian small cell carcinoma | DOID_6179 | |
| central nervous system leukemia | DOID_12969 | [A hematologic cancer located_in the central nervous system.] |
| presbyopia | DOID_11638 | |
| percent interphase cells | BAO_0002042 | [This represents the percentage of cells in a cell population that are preparing for cell division and that exist in either G1, S or G2 phases of the cell cycle. This is calculated by subtracting from the total cell number, the number of cells in the M phase, apoptotic and dead cells in an assay plate.] |
| Buruli ulcer disease | DOID_0050456 | [A primary bacterial infectious disease that results_in infection located_in skin or located_in subcutaneous tissue, has_material_basis_in Mycobacterium ulcerans, which could be transmitted_by insects. The bacterium produces a toxin, named mycolactone, which causes subcutaneous fat necrosis and inhibits an immune response. The infection has_symptom nodule, which is a painless, mobile swelling in the skin.] |
| apoptosis assay | BAO_0002043 | |
| apoptotic process | GO_0006915 | [A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand), and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process, and is typically characterized by rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died.] |
| juvenile myelomonocytic leukemia | DOID_0050458 | |
| primary structure analysis method | BAO_0002045 | |
| Sertoli cell-only syndrome | DOID_0050457 | |
| percent dead cells | BAO_0002046 | [The percentage of cells in an assay that are no longer alive (viable), and show the characteristic features, such as staining with propidium iodide, blurry staining with DAPI, etc.] |
| hyperphosphatemia | DOID_0050459 | |
| p53 activator | CHEBI_77731 | |
| HIV fusion inhibitor | CHEBI_59886 | |
| mucosulfatidosis | DOID_0050441 | |
| pancreatic cystadenoma | DOID_3918 | |
| endocarditis | DOID_10314 | [A endocardium disease characterized by inflammation of the endocardium of the heart chambers and valves.] |
| BT-549 cell | CLO_0002044 | |
| epithelioid sarcoma | DOID_6193 | |
| hereditary spherocytosis | DOID_12971 | [A congenital hemolytic anemia characterized by the production of red blood cells with a sphere shape, rather than the normal biconcave disk shape.] |